Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer

BACKGROUND: Lung immune prognostic index (LIPI) status was recently developed to predict responses to immune checkpoint inhibitor (ICI) treatments. However, it is unclear whether LIPI is a prognostic index for both patients treated with ICI monotherapy and patients treated with ICIs combined with ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wenxian, Huang, Zhangzhou, Yu, Zongyang, Zhuang, Wu, Zheng, Weijun, Cai, Zhijian, Shi, Lei, Yu, Xinmin, Lou, Guangyuan, Hong, Wei, Zhang, Yiping, Chen, Ming, Song, Zhengbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583465/
https://www.ncbi.nlm.nih.gov/pubmed/33163403
http://dx.doi.org/10.3389/fonc.2020.572853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583465/
https://www.ncbi.nlm.nih.gov/pubmed/33163403
http://dx.doi.org/10.3389/fonc.2020.572853

Ejemplares similares